Chu Henri Mondor

Créteil 94010

2 studies enrolling now · 28 studies all time

What they study most

Acute Ischemic Stroke, Acute Respiratory Failure, Alcoholic Hepatitis (AH), B-cell Malignancy, Castration-Resistant Prostate Cancer, Chronic Lymphocytic Leukemia, Chronic Plaque Psoriasis, Diabetic Cardiomyopathies, Diffuse Large B Cell Lymphoma, Disease Progression, FSGS, Focal Segmental Glomerulosclerosis

Studies at this site

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Recruiting now
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
TheraSphere With Durvalumab and Tremelimumab for HCC — Running, not enrolling
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy — Completed
A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) — Completed
IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma — Completed
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). — Completed
A Study of CCX140-B in Subjects With FSGS — Completed
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
Treatment Resistance Following Anti-cancer Therapies — Stopped early
Transthyretin Amyloidosis Outcome Survey (THAOS) — Completed
Safety and Tolerability of Repeat Courses of IM Alefacept — Completed
Phase 2b Study in NASH to Assess IVA337 — Completed
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA — Completed
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia — Completed
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy — Running, not enrolling
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma — Completed
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device — Stopped early
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed
Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) — Completed
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
Third International Study on Mechanical Ventilation — Completed
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke — Stopped early
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer — Completed